Intracellular transactivation of the insulin-like growth factor I receptor by an epidermal growth factor receptor

被引:52
作者
Burgaud, JL [1 ]
Baserga, R [1 ]
机构
[1] THOMAS JEFFERSON UNIV,JEFFERSON CANC CTR,PHILADELPHIA,PA 19107
关键词
D O I
10.1006/excr.1996.0096
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Growth factor receptors may be transactivated not only by homologous receptors, but also by heterologous receptors. We have investigated this possibility, using for this purpose R(-)/EGFR cells, which are mouse embryo cells devoid of IGF-I receptors, but overexpressing the EGF receptor, At variance with mouse embryo cells with a wild-type number of IGF-I receptors and overexpressing the EGF receptor, R(-)/EGFR cells cannot grow in EGF only, nor can they form colonies in soft agar. However, if a wild type human IGF-I receptor is stably transfected into R(-)/EGFR cells, growth in EGF and colony formation in soft agar are restored. To determine a possible interaction between the two receptors, we transfected into R(-)/EGFR cells a number of IGF-I receptor mutants with different impaired functions. The only IGF-I receptor that cannot reverse the growth phenotype of R(-)/EGFR cells is a receptor with a point mutation at the ATP-binding site. All other mutant receptors, even when incapable of responding to IGF-I with a mitogenic signal, made R(-)/EGFR cells fully capable of responding with growth to EGF stimulation. IGF-I receptor mutants that are mitogenic but not transforming made R(-)/EGFR cells grow in EGF only, but were incapable of inducing the transformed phenotype. The mutant IGF-I receptors are activated (tyrosyl phosphorylation of IRS-1) in response to EGF, These experiments indicate that certain IGF-I receptor mutants with loss of function can be reactivated intracellularly by an overexpressed EGF receptor and confirm that the C-terminus of the IGF-IR is required for its transforming activity. (C) 1996 Academic Press, Inc.
引用
收藏
页码:412 / 419
页数:8
相关论文
共 62 条
[11]   A FUNCTIONAL INSULIN-LIKE GROWTH-FACTOR-I RECEPTOR IS REQUIRED FOR THE MITOGENIC AND TRANSFORMING ACTIVITIES OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR [J].
COPPOLA, D ;
FERBER, A ;
MIURA, M ;
SELL, C ;
DAMBROSIO, C ;
RUBIN, R ;
BASERGA, R .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (07) :4588-4595
[12]  
DELALUNA S, 1988, GENE, V62, P121
[13]  
DENANGELIS T, 1995, J CELL PHYSL, V164, P214
[14]   OVEREXPRESSION OF THE HUMAN EGF RECEPTOR CONFERS AN EGF-DEPENDENT TRANSFORMED PHENOTYPE TO NIH 3T3 CELLS [J].
DIFIORE, PP ;
PIERCE, JH ;
FLEMING, TP ;
HAZAN, R ;
ULLRICH, A ;
KING, CR ;
SCHLESSINGER, J ;
AARONSON, SA .
CELL, 1987, 51 (06) :1063-1070
[15]   MUTATIONS OF THE PLATELET-DERIVED GROWTH-FACTOR RECEPTOR THAT CAUSE A LOSS OF LIGAND-INDUCED CONFORMATIONAL CHANGE, SUBTLE CHANGES IN KINASE-ACTIVITY, AND IMPAIRED ABILITY TO STIMULATE DNA-SYNTHESIS [J].
FANTL, WJ ;
ESCOBEDO, JA ;
WILLIAMS, LT .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (10) :4473-4478
[16]   PLASMID-ENCODED HYGROMYCIN-B RESISTANCE - THE SEQUENCE OF HYGROMYCIN-B PHOSPHOTRANSFERASE GENE AND ITS EXPRESSION IN ESCHERICHIA-COLI AND SACCHAROMYCES-CEREVISIAE [J].
GRITZ, L ;
DAVIES, J .
GENE, 1983, 25 (2-3) :179-188
[17]  
GRONBORG M, 1993, J BIOL CHEM, V268, P23435
[18]   C-MYC-INDUCED APOPTOSIS IN FIBROBLASTS IS INHIBITED BY SPECIFIC CYTOKINES [J].
HARRINGTON, EA ;
BENNETT, MR ;
FANIDI, A ;
EVAN, GI .
EMBO JOURNAL, 1994, 13 (14) :3286-3295
[19]  
HELIN K, 1991, ONCOGENE, V6, P825
[20]  
KALEBIC T, 1994, CANCER RES, V54, P5531